ChromaCode Announces Publication of New Study Demonstrating the Superior Performance of its HDPCR NSCLC Assay Compared to NGS with Low Sample Input

/PRNewswire/ -- ChromaCode, Inc., a pioneering genomics multiplexing platform company developing accessible and affordable laboratory-based solutions, today...

Related Keywords

David Schull ,Mark Mcdonough ,Linkedin ,Prnewswire Chromacode Inc ,National Comprehensive Cancer Network ,Twitter ,Chromacode Inc ,Chromacode ,Nc ,